Pharma Pulse: NCPA’s Medicare Negotiation Overhaul Advocacy and Norgine’s $67M UK Supply Investment

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast in which we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and let’s get into today’s headlines.

• The National Community Pharmacists Association is urging CMS to overhaul the Medicare Drug Price Negotiation Program as sixty-seven percent of pharmacies surveyed reported manufacturer refund lags of twenty-two days or more. This model forces owners to float drug acquisition costs against wholesaler terms, leading sixty percent of respondents to dip into personal savings to sustain operations.
• In other news, Norgine is investing thirty-one million dollars to upgrade its facility in Wales, boosting regional supply resilience for gastrointestinal and specialty medicines. This modernization aligns with a broader industry shift toward localized hubs, including Novo Nordisk’s major retrofit in Ireland to scale production for next-generation oral treatments.

That’s it for this episode of Pharma Pulse. For more insights on trends transforming pharmaceutical access and manufacturing, visit pharmaceuticalcommerce.com.

Thanks for listening—until next time, stay well and stay informed

You can catch Pharma Pulse directly on Audioboom, Spotify, or iHeart.